127 related articles for article (PubMed ID: 37076132)
1. Optimal postoperative surveillance strategies for cancer survivors with gastric neuroendocrine carcinoma based on individual risk: a multicenter real-world cohort study.
Xu BB; He XY; Zhou YB; He QL; Tian YT; Hao HK; Qiu XT; Jiang LX; Zhao G; Li Z; Xu YC; Fu WH; Xue FQ; Li SL; Xu ZK; Zhu ZG; Li Y; Li E; Chen JP; Li HL; Cai LS; Wu D; Li P; Zheng CH; Xie JW; Lu J; Huang CM
Int J Surg; 2023 Jun; 109(6):1668-1676. PubMed ID: 37076132
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional development and validation of a nomogram to predict recurrence after curative resection of gastric neuroendocrine/mixed adenoneuroendocrine carcinoma.
Zheng H; Zhao Y; He Q; Hao H; Tian Y; Zou B; Jiang L; Qiu X; Zhou Y; Li Z; Xu Y; Zhao G; Xue F; Li S; Fu W; Li Y; Zhou X; Li Y; Zhu Z; Chen J; Xu Z; Cai L; Li E; Li H; Xie J; Zheng C; Lu J; Li P; Huang C
Gastric Cancer; 2021 Mar; 24(2):503-514. PubMed ID: 32915373
[TBL] [Abstract][Full Text] [Related]
3. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
[TBL] [Abstract][Full Text] [Related]
4. Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
Lu J; Zhao YJ; Zhou Y; He Q; Tian Y; Hao H; Qiu X; Jiang L; Zhao G; Huang CM;
Br J Surg; 2020 Feb; 107(3):248-257. PubMed ID: 31971627
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
Xie JW; Lu J; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Li P; Huang CM
BMC Cancer; 2018 Oct; 18(1):1021. PubMed ID: 30348122
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
7. An international multi-institution real-world study of the optimal surveillance frequency for stage II/III gastric cancer: the more, the better?
Wu D; Lu J; Lin J; Xu BB; Xue Z; Zheng HL; Lin GS; Huang JB; Shen LL; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Ma YB; Truty MJ; Huang CM
Int J Surg; 2023 Dec; 109(12):4101-4112. PubMed ID: 37800589
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma.
Lin J; Zhao Y; Zhou Y; Tian Y; He Q; Lin J; Hao H; Zou B; Jiang L; Zhao G; Lin W; Xu Y; Li Z; Xue F; Li S; Fu W; Li Y; Xu Z; Li Y; Chen J; Zhou X; Zhu Z; Cai L; Li E; Li H; Zheng C; Li P; Huang C; Xie J
JAMA Netw Open; 2021 Jul; 4(7):e2114180. PubMed ID: 34313744
[TBL] [Abstract][Full Text] [Related]
9. Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
Chen J; Wang A; Ji K; Bu Z; Ji J
BMC Cancer; 2020 Aug; 20(1):777. PubMed ID: 32811471
[TBL] [Abstract][Full Text] [Related]
10. The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma.
Deng HY; Li G; Luo J; Li XR; Alai G; Lin YD
World J Surg; 2018 Aug; 42(8):2428-2436. PubMed ID: 29340724
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.
Høeg BL; Bidstrup PE; Karlsen RV; Friberg AS; Albieri V; Dalton SO; Saltbæk L; Andersen KK; Horsboel TA; Johansen C
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31750936
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
14. An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach.
Zhou GQ; Wu CF; Deng B; Gao TS; Lv JW; Lin L; Chen FP; Kou J; Zhang ZX; Huang XD; Zheng ZQ; Ma J; Liang JH; Sun Y
Nat Commun; 2020 Aug; 11(1):3872. PubMed ID: 32747627
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
Morita M; Taguchi K; Kagawa M; Nakanoko T; Uehara H; Sugiyama M; Ota M; Ikebe M; Sugimachi K; Esaki T; Toh Y
Int J Clin Oncol; 2020 May; 25(5):842-850. PubMed ID: 32036480
[TBL] [Abstract][Full Text] [Related]
16. An optimized postsurgery follow-up strategy for patients with esophageal cancer: a cohort study.
Mai Z; Xie J; Leng C; Xie X; Wen J; Yang H; Liu Q; Fu J
Int J Surg; 2024 Jan; 110(1):332-341. PubMed ID: 37916933
[TBL] [Abstract][Full Text] [Related]
17. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
Ma F; Wang B; Xue L; Kang W; Li Y; Li W; Liu H; Ma S; Tian Y
J Cancer Res Clin Oncol; 2020 Aug; 146(8):2135-2142. PubMed ID: 32306127
[TBL] [Abstract][Full Text] [Related]
19. Is lymph node dissection for neuroendocrine carcinoma of the stomach effective as it is for adenocarcinoma?
Yamagata Y; Yoshikawa T; Ishizu K; Kamiya A; Wada T; Hayashi T; Otsuki S; Katai H
Eur J Surg Oncol; 2021 Aug; 47(8):2004-2009. PubMed ID: 33408057
[TBL] [Abstract][Full Text] [Related]
20. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
